Information about Malarone (Atovaquone / Proguanil)
Malarone is a combination medication that includes atovaquone and proguanil. It is primarily used for the prevention and treatment of malaria, particularly in areas where resistance to other antimalarial medications is common.
Product Highlights
- Recommended for travelers going to areas where malaria transmission occurs.
- Effective in treating uncomplicated malaria caused by the Plasmodium falciparum parasite.
Key Ingredient
Key Benefits
- Highly effective against strains of malaria resistant to other treatments.
- Once-daily administration improves adherence.
- Provides quick onset of action for treating active malaria infections.
Direction of Use
- Begin taking Malarone 1 to 2 days before traveling to a malaria-endemic area, continue during the trip, and for 7 days after leaving.
- Follow the prescribed regimen, usually taken for 3 days.
- Best taken with food or a milky drink to enhance absorption.
Safety Concerns
- Common side effects include nausea, vomiting, and abdominal pain.
- Monitoring of liver function is advised, as it may affect those with liver impairment.
- Risk of rash or other skin reactions, including severe cases.
Avoid Malarone (Atovaquone / Proguanil) If
- History of hypersensitivity to atovaquone, proguanil, or any formulation component.
- Not recommended for individuals with severe renal impairment.
- Caution is advised during pregnancy; consult a healthcare provider for alternatives.
